Teitur reports positive early data for Parkinson’s peptide TT‑P34
Phase 1 trial shows strong safety and CNS exposure
Read More
Author: John Pinching
Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer
New data shows nearly three‑year median overall survival
Read More
NICE backs ibrutinib regimen for untreated mantle cell lymphoma
Guidance offers first alternative to transplant‑based first‑line care
Read More
Eric Muller
Lucid Group appointed Eric Muller as Chief Executive Officer
Read More
Andrew Fenny
Andrew Fenny has been appointed President of Pace Life Sciences
Read More
